Pak Fah Yeow International Limited

HK$2.50As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0239Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 1.95%
Div yield 8.00%
ROE 13.76%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.45
PE TTM 7.873
TSR TTM 11.72%
Mkt cap HK$779.1M
ROIC 29.85%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.43
(2.62%)
162.04%
Hold 3|0|6|2|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.05
15.88%
15.39%
13.01%
17.06%
Revenue$M
43.60
43.37
42.32
42.56
1.28%
1.20%
0.42%
(0.56%)
Peers (US$99.38M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.941
(0.036)
(0.030)
EBIT/Intx
1.294
2.101
2.338
Own earn%
364.05
(46.26)
(42.79)
Sh yield%
35.49
19.52
20.50
Owners
Insiders/Inst%
2.00
54.52
Short interest%
3.51
SBC / revenue%
0.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
3